查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1697391

全球人工器官市場－2025年至2030年的預測

Global Artificial Organ Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球人工器官市場預計將從 2025 年的 46.91 億美元成長到 2030 年的 66.87 億美元，預測期內複合年成長率高達 7.35%。

由於 3D 列印、奈米技術和先進人工智慧等趨勢，全球人工器官市場正在擴大。這些技術使得能夠創建具有複雜結構和高生物相容性的患者特定器官。奈米材料擴大被採用來提高產品性能和耐用性。人工智慧將用於設計器官，將功能與患者需求結合，以改善治療並提高成功率。此外，器官捐贈者的短缺也促使等待移植的患者考慮人工器官，從而促進其未來的廣泛使用。

推動人造器官市場成長的因素：

  • 慢性病盛行率上升：慢性病盛行率上升正在推動全球人工器官市場的發展，人工器官為器官功能障礙患者提供了潛在的解決方案。人工器官可以作為器官移植前的臨時支撐或作為終身替代品。在美國，心臟病、癌症、中風、慢性呼吸系統疾病和糖尿病是主要的死亡原因，2023 年分別導致 702,880 人死亡、608,371 人死亡、165,393 人死亡、147,382 人死亡和 101,209 人死亡。
  • 老齡人口增加：全球老齡人口增加正在刺激人工器官市場的發展。與老齡化相關的疾病，如心血管疾病、腎臟疾病、呼吸系統疾病和神經退化性疾病，會隨著器官功能的下降而導致器官衰竭。美國50歲及以上人口預計將從2020年的1.3725億增加到2050年的2.2113億，增幅為61.11%；慢性病患病率預計將從2020年的7152.2萬人增加到2050年的1.4266億，增幅為99.5%。

人造器官市場地理展望

  • 北美：北美憑藉其強大的醫療保健基礎設施、先進技術的高度採用以及龐大的患者群體佔據市場主導地位。例如，美國醫療保健支出到2023年將成長7.5%，達到4.9兆美元，人均14,570美元。
  • 歐洲：歐洲人口老化，醫療保健體系強大，並得到政府重視研究、創新和發展的措施的支持，使得人工器官的使用變得十分成熟。該地區老年人口預計將大幅成長，從 2019 年的 9,050 萬人增至 2050 年的 1.298 億人。
  • 亞太地區：由於經濟轉型、老化社會慢性病增加、政府對醫療設施支出增加以及公眾意識提升，預計亞太地區的人工器官市場將顯著成長。
  • 中東和非洲：醫療保健基礎設施的投資、政府資金的增加以及政府改善醫療保健管道的舉措預計將加強中東和非洲的人工器官市場。
  • 南美：南美地區的人造器官產品銷售量正在增加。由於慢性病盛行率不斷上升、人們意識不斷增強以及醫療保健領域的進步，該地區正在人工器官領域逐步建立品牌股權。

為什麼要購買這份報告？

  • 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 適用範圍廣：對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的歷史資料與預測
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測包括國家在內的細分市場和地區分析
  • 公司概況（特別是主要趨勢）

人造器官市場細分為：

依產品類型

  • 人工心臟
  • 人工腎
  • 人工肺
  • 人工肝
  • 人工胰臟
  • 人工電子耳
  • 其他類型

依器官類型

  • 永久性人造器官
  • 臨時人工器官

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
  • 中東 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 台灣
  • 澳洲
  • 其他

目錄

第1章 引言

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 全球人工器官市場（依產品類型）

  • 介紹
  • 人工心臟
  • 人工腎
  • 人工肺
  • 人工肝
  • 人工胰臟
  • 人工電子耳
  • 其他類型

6. 全球人工器官市場（依器官類型）

  • 介紹
  • 永久性人造器官
  • 臨時人工器官

7. 全球人造器官市場（按地區）

  • 介紹
  • 北美洲
    • 依產品類型
    • 依器官類型
    • 按國家
  • 南美洲
    • 依產品類型
    • 依器官類型
    • 按國家
  • 歐洲
    • 依產品類型
    • 依器官類型
    • 按國家
  • 中東和非洲
    • 依產品類型
    • 依器官類型
    • 按國家
  • 亞太地區
    • 依產品類型
    • 依器官類型
    • 按國家

第8章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第9章 公司簡介

  • Baxter
  • Boston Scientific Corporation
  • Asahi Kasei Medical
  • Medtronic PLC
  • Abiomed
  • SynCardia Systems
  • Carmat
  • Getinge
  • Terumo
  • BiVACOR Inc
簡介目錄
Product Code: KSI061617306

The global artificial organ market is set to witness robust growth at a CAGR of 7.35% during the forecast period to be worth US$6.687 billion in 2030 from US$4.691 billion in 2025.

The global artificial organs market is expanding, driven by trends like 3D printing, nanotechnology, and advanced AI. These technologies enable the creation of patient-specific organs with intricate structures and high biocompatibility. Nanomaterials are increasingly incorporated to enhance product performance and durability. AI is used in organ design and functionality is integrated with patient needs for improved treatment and higher success rates. Furthermore, the shortage of organ donors encourages patients awaiting transplants to consider artificial organs, boosting their future popularity.

Artificial Organ Market Growth Drivers:

  • Increasing Prevalence of Chronic Diseases: The rising incidence of chronic illnesses is driving the global artificial organs market, as these devices offer potential solutions for patients with organ dysfunction. Artificial organs can serve as temporary support before organ transplantation or as lifelong replacements. In America, heart disease, cancer, stroke, chronic lower respiratory diseases, and diabetes are leading causes of death, accounting for 702,880, 608,371, 165,393, 147,382, and 101,209 deaths, respectively, in 2023.
  • Rising Aging Population: The growing global aging population is fueling the development of the artificial organ market. Age-related diseases, such as cardiovascular, kidney, respiratory, and neurodegenerative conditions, along with declining organ function, can lead to organ failure. In the US, the population aged 50 and older is projected to increase by 61.11%, from 137.25 million in 2020 to 221.13 million by 2050, and the prevalence of chronic illness is expected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050.

Artificial Organ Market Geographical Outlook:

  • North America: North America is a dominant market player due to its strong healthcare infrastructure, high adoption of advanced technologies, and a large patient population. For example, healthcare expenses in the US increased by 7.5% to $4.9 trillion in 2023, reaching $14,570 per person.
  • Europe: Europe is well-established in the use of artificial organs due to its aging population and a robust healthcare system supported by government initiatives that emphasize research, innovative technologies, and development. The region's older population is projected to rise significantly, from 90.5 million in 2019 to 129.8 million by 2050.
  • Asia-Pacific: The Asia-Pacific region is expected to experience substantial growth in the artificial organ market due to economic transformations, an increasing prevalence of chronic diseases among the aging population, rising government expenditures on healthcare facilities, and improved public awareness.
  • Middle East and Africa: The artificial organ market in the Middle East and Africa is expected to strengthen, driven by investments in healthcare infrastructure, increasing government funding, and government efforts to improve healthcare access.
  • South America: The South American region is experiencing rising sales of artificial organ products. With the increasing incidence of chronic diseases, growing awareness, and improvements in the health sector, the region is gradually establishing brand equity in the artificial organ sector.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Artificial Organ Market is analyzed into the following segments:

By Product Type

  • Artificial Heart
  • Artificial Kidney
  • Artificial Lungs
  • Artificial Liver
  • Artificial Pancreas
  • Cochlear Implants
  • Other Types

By Organ Type

  • Permanent Artificial Organs
  • Temporary Artificial Organs

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL ARTIFICIAL ORGAN MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Artificial Heart
  • 5.3. Artificial Kidney
  • 5.4. Artificial Lungs
  • 5.5. Artificial Liver
  • 5.6. Artificial Pancreas
  • 5.7. Cochlear Implants
  • 5.8. Other Types

6. GLOBAL ARTIFICIAL ORGAN MARKET BY ORGAN TYPE

  • 6.1. Introduction
  • 6.2. Permanent Artificial Organ
  • 6.3. Temporary Artificial Organ

7. GLOBAL ARTIFICIAL ORGAN MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product Type
    • 7.2.2. By Organ Type
    • 7.2.3. By Country
      • 7.2.3.1. USA
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Product Type
    • 7.3.2. By Organ Type
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Product Type
    • 7.4.2. By Organ Type
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Spain
      • 7.4.3.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Product Type
    • 7.5.2. By Organ Type
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Product Type
    • 7.6.2. By Organ Type
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. Japan
      • 7.6.3.3. India
      • 7.6.3.4. South Korea
      • 7.6.3.5. Taiwan
      • 7.6.3.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Baxter
  • 9.2. Boston Scientific Corporation
  • 9.3. Asahi Kasei Medical
  • 9.4. Medtronic PLC
  • 9.5. Abiomed
  • 9.6. SynCardia Systems
  • 9.7. Carmat
  • 9.8. Getinge
  • 9.9. Terumo
  • 9.10. BiVACOR Inc